Production (Stage)
Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.55B | 2.57B | 2.59B | 2.61B | 2.62B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.55B | 2.57B | 2.59B | 2.61B | 2.62B |
| Cost of Revenue | 753.56M | 751.27M | 755.77M | 761.98M | 764.46M |
| Gross Profit | 1.80B | 1.82B | 1.83B | 1.85B | 1.85B |
| SG&A Expenses | 1.33B | 1.35B | 1.33B | 1.34B | 1.37B |
| Depreciation & Amortization | 363.53M | 373.55M | 381.55M | 386.28M | 365.18M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.74B | 2.78B | 2.79B | 2.82B | 2.84B |
| Operating Income | -186.65M | -208.79M | -196.55M | -214.68M | -224.52M |
| Income Before Tax | -1.03B | -993.65M | -970.86M | -997.92M | -230.26M |
| Income Tax Expenses | -13.35M | 7.59M | 10.87M | 7.61M | 2.77M |
| Earnings from Continuing Operations | -1.01K | -1.00K | -981.73 | -1.01K | -233.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.01B | -1.00B | -981.73M | -1.01B | -233.03M |
| EBIT | -186.65M | -208.79M | -196.55M | -214.68M | -224.52M |
| EBITDA | 32.82M | 31.72M | 63.58M | 63.36M | 43.43M |
| EPS Basic | -5.93 | -5.88 | -5.78 | -5.93 | -1.40 |
| Normalized Basic EPS | -0.57 | -0.67 | -0.58 | -0.68 | -0.73 |
| EPS Diluted | -5.93 | -5.88 | -5.78 | -5.93 | -1.40 |
| Normalized Diluted EPS | -0.57 | -0.67 | -0.58 | -0.68 | -0.73 |
| Average Basic Shares Outstanding | 688.65M | 682.22M | 675.52M | 669.14M | 663.08M |
| Average Diluted Shares Outstanding | 688.65M | 682.22M | 675.52M | 669.14M | 663.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |